PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 25.05 CHF 1.01% Market Closed
Market Cap: 829.9m CHF

Wall Street
Price Targets

PPGN Price Targets Summary
PolyPeptide Group AG

Wall Street analysts forecast PPGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPGN is 35.48 CHF with a low forecast of 29.29 CHF and a high forecast of 46.2 CHF.

Lowest
Price Target
29.29 CHF
17% Upside
Average
Price Target
35.48 CHF
42% Upside
Highest
Price Target
46.2 CHF
84% Upside
PolyPeptide Group AG Competitors:
Price Targets
ABSI
Absci Corp
133% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
35% Upside
WAT
Waters Corp
6% Upside
GUBRA
Gubra A/S
32% Upside
CGEN
Compugen Ltd
328% Upside
SHC
Sotera Health Co
16% Upside
300759
Pharmaron Beijing Co Ltd
29% Upside
603108
Shanghai Runda Medical Technology Co Ltd
60% Upside

Revenue
Forecast

Revenue Estimate
PolyPeptide Group AG

For the last 5 years the compound annual growth rate for PolyPeptide Group AG's revenue is 11%. The projected CAGR for the next 4 years is 18%.

11%
Past Growth
18%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Net Income
Forecast

Net Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PPGN's stock price target?
Price Target
35.48 CHF

According to Wall Street analysts, the average 1-year price target for PPGN is 35.48 CHF with a low forecast of 29.29 CHF and a high forecast of 46.2 CHF.

What is PolyPeptide Group AG's Revenue forecast?
Projected CAGR
18%

For the last 5 years the compound annual growth rate for PolyPeptide Group AG's revenue is 11%. The projected CAGR for the next 4 years is 18%.

Back to Top